- The Trump administration launched an investigation into Harvard's patents derived from federally funded research, citing potential violations of the Bayh-Dole Act.
- Harvard was accused of failing to disclose federally funded inventions timely, ensure U.S. manufacturing for licensed technologies, and maximize public benefit.
- Harvard holds over 58,000 patents and maintains 900+ active technology licenses, with significant collaborations in biotechnology, medical devices, and pharmaceuticals.
- The investigation is part of a broader campaign by the Trump administration against Harvard, including allegations of antisemitism, financial misconduct, and ties with China.
- If found noncompliant, Harvard could lose control over certain patents, as the government may exercise 'march-in rights' under the Bayh-Dole Act.
- Negotiations between Harvard and the White House for a possible settlement are ongoing, with Trump pushing for a major financial settlement.